Starton Holdings, Inc. (STA)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	226.34M
Revenue (ttm)	n/a
Net Income	-9.28M
EPS	-0.25
Shares Out	37.72M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About STA

Starton is a clinical-stage biotechnology company focused on improving standard-of-care therapies for people with cancer through application of our proprietary platform of delivery technology systems. We use continuous delivery of FDA-approved, active ingredients in an attempt to develop and bring products to market in either new indications or with enhanced outcomes in existing indications. In collaboration with our consulting company, McKinsey & Company, we evaluated over 80,000 potential applications to identify those applications where we b...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2017
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: STA
• Website: https://www.startontx.com/

Financial Performance

Data Source: SEC filings Last updated: Aug 20, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error